Ledger Run Enhances ClinRun Platform with AI for Streamlined Clinical Trial Payments
Ledger Run has upgraded its ClinRun platform to incorporate AI-driven automation, enhancing the efficiency of clinical trial payment processes. This development addresses the high demand for improved payment experiences in a landscape marked by a growing number of clinical trials and limited resources.
Theia Market Signal Identification - AI Assisted
Ledger Run has implemented significant upgrades to its ClinRun platform, introducing AI-powered automation to streamline site payments and invoice processing. This enhancement aims to alleviate the burden of manual tracking, which consumes up to 70% of organizations' time, thereby accelerating and improving the accuracy of payments to research sites.
In 2024, the American Society of Clinical Oncology noted 6,710 open trials across 1,836 sites, emphasizing the increasing demand for efficient payment systems. As specialty sites become critical for novel therapies, the ability to ensure timely compensation can influence sponsorship decisions. The integration of AI into ClinRun positions Ledger Run to support clinical trial operations under pressure to enhance speed and compliance.
Comments